Smith & Nephew PLC SN.-GB:London Stock Exchange
RT Quote | Exchange | GBp
Last | 4:53 PM BST
1,108.50
+17.00 (+1.56%)
+17.00 (+1.56%)52 week range
1,050.00 - 1,441.50
- Open1,094.50
- Day High1,117.00
- Day Low1,093.50
- Prev Close1,091.50
- 52 Week High1,441.50
- 52 Week High Date09/10/25
- 52 Week Low1,050.00
- 52 Week Low Date05/20/26
Latest On Smith & Nephew PLC
Key Stats
- Market Cap9.425B
- Shares Out850.21M
- 10 Day Average Volume2.72M
- Dividend29.04
- Dividend Yield2.62%
- Beta1.12
Latest On Smith & Nephew PLC
KEY STATS
- Open1,094.50
- Day High1,117.00
- Day Low1,093.50
- Prev Close1,091.50
- 52 Week High1,441.50
- 52 Week High Date09/10/25
- 52 Week Low1,050.00
- 52 Week Low Date05/20/26
- Market Cap9.425B
- Shares Out850.21M
- 10 Day Average Volume2.72M
- Dividend29.04
- Dividend Yield2.62%
- Beta1.12
RATIOS/PROFITABILITY
- EPS (TTM)53.54
- P/E (TTM)20.70
- Fwd P/E (NTM)-
- EBITDA (TTM)1.194B
- ROE (TTM)11.84%
- Revenue (TTM)4.583B
- Gross Margin (TTM)68.01%
- Net Margin (TTM)10.14%
- Debt To Equity (MRQ)62.90%
EVENTS
- Earnings Date-
- Ex Div Date03/26/2026
- Div Amount0.1778
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MORESmith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT...
Rupert Soames OBE
Non-Executive Independent Chairman of the Board
Deepak Nath
Chief Executive Officer, Executive Director
John Rogers
Chief Financial Officer, Executive Director
Helen Barraclough
Group General Counsel, Company Secretary
Address
Building 5, Croxley Park, Hatters Lane
Watford
WD18 8YE
United Kingdom